Showing 21-30 of 5643 results for "".
- November/December 2019 Supplement - MOD Issueshttps://modernod.com/mod-issues/novemberdecember-2019-supplement/
- January/February 2018 ISSUE - MOD Issueshttps://modernod.com/mod-issues/2018-jan-feb/
- October 2022 Insert - MOD Issueshttps://modernod.com/mod-issues/2022-oct-insert3/
Initial Visits and Long-term Care of Glaucoma Patients in Primary Eye Care Settings
https://modernod.com/topics/glaucoma/initial-visits-and-long-term-care-of-glaucoma-patients-in-primary-eye-care-settings-1/36866/Which technologies are essential to conducting a thorough examination for new glaucoma patients? And which modalities and softwares are most useful for long-term care? Danica Marrelli, OD, and Anu Laul, OD, compare their approaches to initial encounters with glaucoma patients, swap notes on their prPhase 3 Results for Novel Sedation Tablet
https://modernod.com/podcasts/eyewire-news-the-podcast/phase-3-results-for-novel-sedation-tablet/37062/New phase 3 data is released for a non-opioid sedation tablet; the first patient is dosed in the phase 3 trial of EyePoint’s wet AMD candidate; and Outlook receives a reimbursement decision in the UK for its wet AMD treatment. Learn more about your ad choices. Visit megaphone.fm/adchoicesSpecial Report: TFOS DEWS III Leaders Discuss New DED Guidance
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-tfos-dews-iii-leaders-discuss-new-ded-guidance/39867/Leaders from the Tear Film and Ocular Surface Society discuss the biggest takeaways from the recently released TFOS DEWS III report. Learn more about your ad choices. Visit megaphone.fm/adchoicesTryptyr Now Available in US
https://modernod.com/podcasts/eyewire-news-the-podcast/tryptyr-now-available-in-us/37095/Alcon launches its recently approved dry eye drug Tryptyr; a potential $1 billion deal is made to advance extended-release therapies for eye diseases; and two companies with late-stage AMD drug candidates complete phase 3 enrollment. Learn more about your ad choices. Visit megaphone.fm/adchoicesNorlase Launches First Pattern Scanning LIO
https://modernod.com/podcasts/eyewire-news-the-podcast/norlase-launches-first-pattern-scanning-lio/37069/The world’s first and only pattern scanning laser indirect ophthalmoscope is approved in the US and Europe; the European Commission approves a biosimilar to Eylea; and we review several clinical updates in the development of ophthalmic drugs. Learn more about your ad choices. Visit megaphone.fm/adchB+L Bolsters Glaucoma Offerings with Elios Acquisition
https://modernod.com/podcasts/eyewire-news-the-podcast/bl-bolsters-glaucoma-offerings-with-elios-acquisition/37063/Bausch + Lomb makes an acquisition to expand its glaucoma offerings; Roche gets a major approval in Europe for Vabysmo; and EssilorLuxottica buys a maker of noninvasive ophthalmic medical devices. Learn more about your ad choices. Visit megaphone.fm/adchoicesPhakic IOL for Presbyopia Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/phakic-iol-for-presbyopia-approved-in-europe/37061/A new phakic IOL for presbyopia is approved in Europe; Nidek launches its preloaded Toric IOL Injection System internationally; and the FDA cleared a novel device for the treatment of Meibomian Gland Dysfunction. Learn more about your ad choices. Visit megaphone.fm/adchoices